Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-10 of 10 for your search:
Drug:
recombinant human stem cell factor
Find trials that include:
Any drugs shown
Trial Status:
Closed
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase III Randomized Study of Hematologic Parameters to Maximize CD34+ Harvest and Initiate Leukapheresis Following Peripheral Blood Stem Cell Mobilization With Cyclophosphamide, Paclitaxel, Filgrastim (G-CSF), and Stem Cell Factor in Patients With Stage II, III, or IV Breast Cancer (Summary Last Modified 01/2000)
Phase:
Phase III
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
NCI, Pharmaceutical / Industry
Protocol IDs:
CWRU-AMGN-1198
, AMGEN-SCF-980165, NCI-G99-1547
2.
Phase I/II Study of Peripheral Blood Progenitor Cell (PBPC) Mobilization in Response to Human Stem Cell Factor +/- G-CSF and of the Efficacy of PBPC plus G-CSF as a Rescue Regimen Following Myeloablative Chemotherapy in High-Risk Stage II and Stage III/IV Breast Cancer (Summary Last Modified 11/94)
Phase:
Phase II, Phase I
Type:
Treatment
Status:
Completed
Age:
18 to 62
Sponsor:
Protocol IDs:
UCLA-HSPC-9303106
, NCI-V94-0503
3.
Phase I/II Randomized Study of PBPC Mobilized with r-metHuSCF and/or G-CSF in Patients with Intermediate- or Immunoblastic High-Grade non-Hodgkin's Lymphoma (Summary Last Modified 10/93)
Phase:
Phase II, Phase I
Type:
Treatment
Status:
Completed
Age:
18 to 65
Sponsor:
Protocol IDs:
MSKCC-93060
, NCI-V93-0270
4.
Phase II Randomized Study of Stem Cell Factor vs G-CSF for Mobilization of Peripheral Blood Progenitor Cells in Heavily Pretreated Patients with non-Hodgkin's Lymphoma or Hodgkin's Disease (Summary Last Modified 08/97)
Phase:
Phase II
Type:
Treatment
Status:
Completed
Age:
18 to 65
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
AMGEN-SCF-950123
, NCI-V96-0956
5.
Randomized Phase II Study of Filgrastim and Stem Cell Factor (r-metHuSCF) in Priming of Bone Marrow for Autologous Transplantation in Patients with Relapsed or Refractory Hodgkin's Disease (HD) or Non-Hodgkin's Lymphoma (NHL) (Summary Last Modified 10/98)
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
RPCI-DS-96-24
, NCI-G97-1153
6.
Phase II Study of Sequential High Dose Chemotherapy With Cyclophosphamide and Paclitaxel, Mitoxantrone and Cytarabine, and Etoposide and Melphalan Plus Autologous Peripheral Blood Stem Cell Transplantation in Patients With Chemotherapy Sensitive Relapsed Non-Hodgkin's Lymphoma (Summary Last Modified 11/2000)
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
FCCC-98052
, NCI-G99-1541, NCT00003957
7.
Phase II Pilot Study of High-Dose Ifosfamide/Carboplatin/Etoposide (ICE) Followed by Transplantation with neo-r-Transduced Autologous Bone Marrow and PBSC for Metastatic Breast Cancer
Phase:
Phase II
Type:
Treatment
Status:
Completed
Age:
18 to 60
Sponsor:
NCI
Protocol IDs:
NCI-92-C-0161I
, NCI-MB-294, NCI-T92-0018N, T92-0018
8.
Phase II Study of High-Dose L-PAM and TBI with Autologous Bone Marrow and PBSC Support Followed by IFN-A for Multiple Myeloma, with Genetic Marking with Retroviral Vectors to Study the Feasibility of Stem Cell Gene Transfer and the Biology of Hematologic Reconstitution
Phase:
Phase II
Type:
Treatment
Status:
Completed
Age:
up to 65
Sponsor:
NHLBI
Protocol IDs:
NHLBI-92-H-57
, NCI-T92-0139N, T92-0139
9.
Phase I Pilot Study of Sequential High-Dose Chemotherapy for Stage IV Breast Cancer: Methotrexate/Fluorouracil/Leucovorin, Cyclophosphamide, Thiotepa with Peripheral Blood Stem Cell Rescue (with MDR1 and NeoR Gene Transduction of Cells), Paclitaxel, and Doxorubicin (Summary Last Modified 08/2000)
Phase:
Phase I
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
NCI-96-C-0007K
, NCI-MB-361, NCI-T95-0096N, T95-0096
10.
Phase I Study of Low-Dose Interleukin-2 and Stem Cell Factor in Patients With AIDS or AIDS-Related Malignancies
Phase:
Phase I
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
RPCI-RP-9911
, NCT00058045
Select All on Page
Help with Results
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute